Autolus Therapeutics plc Forecast, price target & analysts
Autolus Therapeutics plc Target price 2025 - Analyst rating & recommendation
Autolus Therapeutics plc Classifications & Recommendation:
Autolus Therapeutics plc Price Target
| Target Price | $9.89 |
| Price | $1.51 |
| Potential |
554.97%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Autolus Therapeutics plc 2026 .
The average Autolus Therapeutics plc target price is $9.89.
This is
554.97%
register free of charge
$14.00
827.15%
register free of charge
$6.00
297.35%
register free of charge
|
|
| A rating was issued by 11 analysts: 11 Analysts recommend Autolus Therapeutics plc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Autolus Therapeutics plc stock has an average upside potential 2026 of
554.97%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 10.12 | 36.83 |
| 495.29% | 263.90% | |
| EBITDA Margin | -2,108.40% | -588.57% |
| 80.98% | 72.08% | |
| Net Margin | -2,261.58% | -644.39% |
| 87.96% | 71.51% |
10 Analysts have issued a sales forecast Autolus Therapeutics plc 2025 . The average Autolus Therapeutics plc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Autolus Therapeutics plc EBITDA forecast 2025. The average Autolus Therapeutics plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Autolus Therapeutics plc Analysts have issued a net profit forecast 2025. The average Autolus Therapeutics plc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.86 | -0.89 |
| 28.33% | 3.49% | |
| P/E | negative | |
| EV/Sales | 2.98 |
5 Analysts have issued a Autolus Therapeutics plc forecast for earnings per share. The average Autolus Therapeutics plc EPS is
This results in the following potential growth metrics and future valuations:
Autolus Therapeutics plc...
Current Autolus Therapeutics plc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jan 13 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Dec 09 2024 |
| Needham |
Locked
➜
Locked
|
Locked | Dec 05 2024 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
| Redburn Atlantic |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jan 13 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Dec 09 2024 |
|
Locked
Needham:
Locked
➜
Locked
|
Dec 05 2024 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Nov 18 2024 |
|
Locked
Redburn Atlantic:
Locked
➜
Locked
|
Nov 15 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
